Current Hpv News and Events | Page 25

Current Hpv News and Events, Hpv News Articles.
Sort By: Most Relevant | Most Viewed
Page 25 of 25 | 983 Results
Hutchinson Center study suggests HPV 18 may be useful for predicting prognosis of invasive cervical cancer
Researchers at the Fred Hutchinson Cancer Research Center in Seattle have published the results of the largest, most comprehensive and first population-based study to assess the viability of HPV 18 as a prognostic tumor marker for invasive cervical cancer. The results confirm those of several previous, smaller studies that found HPV 18 to be associated with a mortality rate nearly double that of other HPV-related cervical cancers. (2001-03-28)

Scientists identify new vaccine targets for cancer-causing strains of human papilloma virus
Epimmune Inc. announced today that Company scientists and academic collaborators identified new vaccine targets for cancer-causing strains of the human papilloma virus. The scientists reported the discovery of four protein fragments that can induce a cellular immune response and may lead to an effective vaccine for treatment and prevention of CIN and cervical cancer. (2001-03-26)

Vinegar plus HPV test identifies women at risk for cervical cancer
A lab test for the human papilloma virus (HPV) combined with a visual inspection of the cervix could identify pre- cancerous lesions and vastly reduce the number of false positives among women at high risk for cervical cancer in developing countries, according to researchers at Johns Hopkins and the University of Zimbabwe. (2001-02-01)

Postmenopausal women may not need annual pap smear, UCSF study finds
Some postmenopausal women may not need to have Pap smears within two years of a normal test result, a University of California, San Francisco study has found. This is because it is unlikely these women will have significant abnormalities within that time frame, the researchers said. (2000-12-18)

UT Southwestern study shows ThinPrep Pap tests could help develop markers for risk of cervical cancers
A UT Southwestern Medical Center study proves that a recently developed fluid-based Pap test offers a relatively simple way for molecular changes in cell samples to be analyzed. (2000-10-09)

Study finds women screened for cervical cancer one, two and three years after normal test results have same low rate of abnormalities
Women who undergo Pap smear tests to screen for cervical cancer one, two or three years after having had normal test results had about the same low rate of significant cellular abnormalities, a University of California, San Francisco study has found. (2000-07-30)

Anal cancer screening for gay and bisexual men would save lives and be cost effective, new study shows
Just as use of Pap smears has led to a dramatic drop in cervical cancer, so screening for anal cancer among gay men would save many lives at a reasonable cost, according to a study conducted at the Harvard School of Public Health and University of California at San Francisco. (2000-05-31)

Hopkins scientists link human papillomavirus (HPV) to head and neck cancer
Researchers at the Johns Hopkins School of Medicine and School of Hygiene and Public Health have found the sexually transmitted human papillomavirus (HPV) to be a likely cause of certain cancers of the head and neck and also an indicator of improved survival. Their findings are reported in the May 3, 2000, issue of the Journal of the National Cancer Institute. (2000-05-02)

Alternative to Pap smear could reduce cervical cancer deaths
Self-administered HPV testing is simpler than a Pap smear and could help increase the number of women screened for cervical cancer in both the developed and developing worlds. Dr. Thomas Wright, associate professor of pathology at Columbia University, is lead author of the study appearing in the Jan. 5 issue of the Journal of the American Medical Association. (2000-01-03)

Study examines STDs among women-to-women sex partners
Researchers at the University of Washington have begun the first extensive study of lesbian and bisexual women and sexually transmitted diseases. Researchers are discussing some of their tentative findings on a new Web site,, to attract more volunteers. (1999-10-19)

Yale cancer center to test cervical cancer prevention drug: NCI grant funds research
The Yale Cancer Center has received a $1.3 million grant from the NCI to conduct a clinical trial of a new drug designed to suppress HPV infections and prevent cervical cancer. Indole 3 carbinole will be tested in a multiinstitutional phase III trial of 200 people with chronic genital HPV. (1999-10-14)

New biomarker for cervical cancer
University of North Carolina at Chapel Hill researchers are studying the value of a new biomarker for improving cervical cancer screening. The clinical trial will examine cervical smears for telomerase, a protein released into cells when chromosomes shorten, stick together and become genetically unstable. (1999-09-30)

Wistar immunologists awarded grants to promote the development of vaccinesagainst HIV-1 and human papilloma viruses
Three Wistar Immunologists have been awarded grants to support their development of vaccines against diseases that attack the mucous membranes, such as HIV-1 and Human Papilloma Viruses. (1999-07-06)

Topical Agent Found To Kill Papillomavirus
A common surfactant and detergent found in many shampoos and toothpastes is the first topical microbicidal agent shown to kill animal and human papillomavirus, according to a Penn State researcher. Sodium dodecyl sulfate was found in cell culture and animal testing to inactivate sexually transmitted viruses including HIV,HSV-2 and HPVs. (1999-02-12)

Nationwide Study Finds HIV-Positive Women Are At High Risk For Cervical Human Papillomavirus Infection
In the largest study of its kind, a national team led by a UC San Francisco scientist has found strong new evidence that HIV-positive women run a high risk of infection with human papillomavirus (HPV), a major cause of cervical cancer. (1999-02-03)

Wistar Scientist Awarded Cancer Research Foundation Of America Grant To Develop Vaccine For Human Papilloma Virus
Dr. Hildegund Ertl of Philadelphia's Wistar Institute has been awarded a two-year $30,000 grant from the Cancer Research Foundation of America. This grant allows her to continue her work to find a vaccine for Human Papilloma Virus-16 (HPV-16), a sexually transmitted virus that can lead to cervical cancer. (1999-01-22)

Innovative Database Developed For The Study Of Sexually Transmitted Diseases
A database designed to accelerate research on sexually transmitted diseases (STDs) is now (1998-10-22)

Health Promotion: Can Scare Tactics Work?
Health promotion campaigns based on scare tactics may produce the opposite of the intended effects if they don't also make people believe they can do something that really averts the health threat, warns a team of researchers who field tested one such campaign -- about genital warts -- among coeds at Michigan State University. (1998-09-01)

Major Risk Factor For Cervical Cancer Found
Scientists have found that women who carry a particular variation of the tumour suppressor gene p53 are seven times more likely to develop cervical cancer that those who do not. (1998-05-21)

Sexually Active Younger Women Are At Higher Risk For Infection With Human Papillomavirus
Sexually active college-age women have a high incidence of human papillomavirus (HPV) infection according to a study supported by the National Institute of Allergy and Infectious Diseases (NIAID)and reported in the Feb. 12, 1998 issue of The New England Journal of Medicine. (1998-02-11)

Cervical Cancer - Putting Anti-Viral White Blood Cells To Work
In about 30% of women with an early, preinvasive form of cervical cancer the precancerous cells are cleared from the body without any treatment, suggesting that the immune system is at work. British researchers are trying to use the immune system to help all women with the disease. (1997-12-01)

New Steps Found In Deadly Path Of Cancer-Causing Virus: Findings Suggest Novel Method Of Stopping Cervical Cancer In Its Tracks
Researchers at Harvard Medical School report in the April Journal of Virology that the two viral genes of human papillomavirus, E6 and E7, that together can cause cancer, may work more similarly than previously thought, targeting and degrading tumor-supressor proteins in human cells. The findings suggest new therapies against cervical cancer (1997-04-15)

Physicians Begin Testing First Human Papillomavirus Vaccine
Physicians at the University of Rochester Medical Center are beginning the world's first test in humans of a potential vaccine to protect against human papillomavirus (HPV) infections, one of the most common sexually transmitted diseases. The disease causes warts of the genital tract and causes nearly all cases of cervical cancer in women (1997-02-03)

Page 25 of 25 | 983 Results
   First   Previous   Next      Last is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to